Senti Biosciences (SNTI) Change in Cash (2021 - 2025)

Senti Biosciences has reported Change in Cash for 5 years, with the latest figure at $4.2 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash fell 88.97% year-over-year to $4.2 million; the trailing twelve-month figure through Dec 2025 stood at -$31.9 million (down 357.68% YoY), and the FY2025 full-year result was -$31.9 million, down 357.68% from the prior year.
• Change in Cash for Q4 2025 stood at $4.2 million, up from -$9.3 million in the prior quarter.
• The five-year high for Change in Cash was $101.7 million in Q2 2022, with the low at -$57.2 million in Q4 2022.
• Average Change in Cash over 5 years is -$1.9 million, with a median of -$6.4 million recorded in 2023.
• Peak annual rise in Change in Cash reached 9167.98% in 2022, while the deepest fall reached 6537.26% in 2022.
• Tracing SNTI's Change in Cash over 5 years: stood at $889323.0 in 2021, then plunged by 6537.26% to -$57.2 million in 2022, then jumped by 88.86% to -$6.4 million in 2023, then soared by 692.08% to $37.8 million in 2024, then slumped by 88.97% to $4.2 million in 2025.
• The last three Change in Cash figures came in at $4.2 million (Q4 2025), -$9.3 million (Q3 2025), and -$12.2 million (Q2 2025), per Business Quant data.

Peer Comparison